Most people do not survive out-of-hospital cardiac arrest, and those who do may have
substantial long-term cognitive and motor impairment. ICDs may avert such events. This …

Implantable cardioverter defibrillators (ICDs) have evolved from the treatment of last resort to
the gold standard therapy for patients at high risk for ventricular tachyarrhythmias. High-risk …

Background—Successful antitachycardia pacing (ATP) terminates ventricular tachycardia
(VT) up to 250 bpm without the need for painful shocks in implantable cardioverter …

Objectives: The purpose of the study was to evaluate the efficacy and safety of the entirely
subcutaneous implantable cardioverter-defibrillator (S-ICD). Background: A new entirely S …

BACKGROUND: Implantable cardioverter-defibrillators (ICDs) are widely used to prevent
fatal outcomes associated with life-threatening arrhythmic episodes in a variety of cardiac …

Background—In patients with implantable cardioverter-defibrillators (ICDs), antitachycardia
pacing (ATP) is highly effective in terminating fast ventricular tachycardias (FVTs) and lowers …

Focuses on the antitachycardia pacing for ventricular tachycardia. Use of implantable
cardioverter defibrillators on ventricular tachycardia; Pathophysiological basis for sustained …

Large-scale implantable cardioverter defibrillator (ICD) trials have unequivocally shown a
reduction in mortality in appropriately selected patients with heart failure and depressed left …

Several studies have analyzed the efficacy of a variety of antitachycardia pacing (ATP)
modalities in induced and spontaneous monomorphic ventricular tachycardia (MVT). 1–18 …

Antitachycardia pacing for the termination of ventricular tachycardia (VT) is a standard
feature of implantable cardioverter-defibrillators (ICDs). New generation tiered-therapy …